Aspira Women's Health Inc. 10-Q Filing

From the Filing

0000926617-25-000008.txt : 20251114 0000926617-25-000008.hdr.sgml : 20251114 20251114160812 ACCESSION NUMBER: 0000926617-25-000008 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20250930 FILED AS OF DATE: 20251114 DATE AS OF CHANGE: 20251114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 251486024 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 10-Q 1 awhl-20250930x10q.htm 10-Q Aspira Women’s Health Inc._September 30, 2025 0000926617 Q3 2025 --12-31 false P3Y 0 0 0 0 P1Y P3Y http://fasb.org/us-gaap/2025#FairValueAdjustmentOfWarrants 0000926617 awhl:TwoThousandAndTwentyTwoWarrantsMember 2025-09-30 0000926617 awhl:MarchTwoThousandAndTwentyFiveWarrantsMember 2025-09-30 0000926617 awhl:FairValueOfMarchTwoThousandTwentyFiveWarrantsMember 2025-09-30 0000926617 awhl:FairValueOfAugustTwoThousandTwentyTwoWarrantsMember 2025-09-30 0000926617 awhl:MarchTwoThousandAndTwentyFiveWarrantsMember 2025-03-12 0000926617 awhl:TwoThousandAndTwentyTwoWarrantsMember 2024-12-31 0000926617 awhl:FairValueOfAugustTwoThousandTwentyTwoWarrantsMember 2024-12-31 0000926617 awhl:AmendedLoanAgreementMember 2025-09-30 0000926617 awhl:AmendedLoanAgreementMember 2024-12-31 0000926617 us-gaap:ConvertibleDebtMember 2025-01-01 2025-09-30 0000926617 awhl:TwentyTwentyFourPrivatePlacementOfferingMember 2025-02-01 2025-02-28 0000926617 awhl:TwentyTwentyFivePrivatePlacementOfferingMember awhl:PurchaseAgreementMember 2025-09-16 2025-09-16 0000926617 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000926617 awhl:SecuritiesPurchaseAgreementsMember 2024-08-01 2024-08-31 0000926617 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000926617 srt:ChiefExecutiveOfficerMember awhl:TwentyTwentyFourRegisteredDirectOfferingMember 2024-01-24 2024-01-24 0000926617 awhl:InvestorsMember awhl:TwentyTwentyFourRegisteredDirectOfferingMember 2024-01-24 2024-01-24 0000926617 2025-03-12 2025-03-12 0000926617 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000926617 us-gaap:RetainedEarningsMember 2025-09-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0000926617 us-gaap:RetainedEarningsMember 2025-06-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000926617 2025-06-30 0000926617 us-gaap:RetainedEarningsMember 2025-03-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000926617 2025-03-31 0000926617 us-gaap:RetainedEarningsMember 2024-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000926617 us-gaap:RetainedEarningsMember 2024-09-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000926617 us-gaap:RetainedEarningsMember 2024-06-30 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000926617 2024-06-30 0000926617 us-gaap:RetainedEarningsMember 2024-03-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000926617 2024-03-31 0000926617 us-gaap:RetainedEarningsMember 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000926617 us-gaap:CommonStockMember 2025-09-30 0000926617 us-gaap:CommonStockMember 2025-06-30 0000926617 us-gaap:CommonStockMember 2025-03-31 0000926617 us-gaap:CommonStockMember 2024-12-31 0000926617 us-gaap:CommonStockM